Release Date: Aug 2018
CC: PC, MK, PBL, ICS, PR, SBP
Michelle S. Hirsch, MD, PhD
Chief of Genitourinary Pathology, Brigham and Women’s Hospital, Boston, MA; Associate Professor of Pathology, Harvard Medical School, Boston, MA
Accurate subclassification of adult renal tumors is important for patient care as it can influence prognosis and therapeutic options. Accordingly, this webcast will begin by providing recent updates to the 2016 WHO Classification of adult renal tumors. Emphasis will be placed on distinct morphologic features, biomarker evaluation, and genetic/molecular studies that have been used to help subclassify these tumors. These features will then be discussed in core biopsy specimens, as findings and interpretation can be more difficult with limited tissue samples. By the end of the webcast, the viewer should have a better understanding of renal tumor subclassification and interpretation of limited tissue specimens.
After attending this session, participants will be able to:
- List recent updates in the WHO Classification of adult renal tumors.
- Use morphologic, immunohistochemical, and molecular studies to help subclassify kidney tumors.
- Make accurate diagnoses in limited samples (i.e., core biopsies) from kidney masses.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Pathologists’ Assistants, Cytotechnologists, Pathology Fellows, Students